Live from the NIH registry
Studies recruiting near Bakersfield right now
Top 25 of 71 recruiting studies, sorted by proximity — each links to its official registry page
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 355 participants sought
Kern Research Inc. — Bakersfield, California (1.7 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD)
Phase 2
Interventional 324 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi)
· Sponsor: ONL Therapeutics
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
California Retina Consultants-Bakersfield-65523 — Bakersfield, California (1.7 mi)
· Sponsor: Boehringer Ingelheim
Study to Evaluate the Efficacy of a Single Intravitreal Injection of RTx-015 in Participants With Retinitis Pigmentosa (PERCEPT)
Retinitis Pigmentosa (RP), Inherited Retinal Diseases
Phase 2, Phase 3
Interventional 60 participants sought
RayTx Clinical Site — Bakersfield, California (1.7 mi)
· Sponsor: Ray Therapeutics, Inc.
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Chronic Inducible Urticaria, Cold Urticaria
Phase 3
Interventional 240 participants sought
Kern Research, Inc. — Bakersfield, California (1.7 mi)
· Sponsor: Celldex Therapeutics
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Bakersfield, California (1.7 mi)
· Sponsor: Medtronic
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Obesity or Overweight, Diabetes Mellitus, Type 2
Phase 3
Interventional 1,500 participants sought
Research Site — Bakersfield, California (1.7 mi)
· Sponsor: AstraZeneca
Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
Retinitis Pigmentosa
Phase 2
Interventional 60 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi)
· Sponsor: jCyte, Inc
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Bladder (Urothelial, Transitional Cell) Cancer, Non-Muscle Invasive Bladder Carcinoma
Phase 3
Interventional 284 participants sought
Michael Oefelein Clinical Trials — Bakersfield, California (1.7 mi)
· Sponsor: Protara Therapeutics
Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
Solid Tumor
Phase 1, Phase 2
Interventional 100 participants sought
CBCC Global Research Site 005 — Bakersfield, California (1.7 mi)
· Sponsor: Alyssum Therapeutics
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
CBCC Global Research — Bakersfield, California (1.7 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
Diabetic Retinopathy
Phase 2
Interventional 175 participants sought
California Retina Consultants-Bakersfield-65523 — Bakersfield, California (1.7 mi)
· Sponsor: Boehringer Ingelheim
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Diabetic Macular Edema, DME
Phase 3
Interventional 240 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi)
· Sponsor: EyePoint Pharmaceuticals, Inc.
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms
Phase 2
Interventional 308 participants sought
Michael G Oefelein Clinical Trials ( Site 0138) — Bakersfield, California (1.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Colorectal Neoplasms
Phase 3
Interventional 700 participants sought
CBCC Global Research — Bakersfield, California (1.7 mi)
· Sponsor: Janssen Research & Development, LLC
Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease
Stargardt Disease
Phase 1, Phase 2
Interventional 18 participants sought
RayTx Clinical Site — Bakersfield, California (1.7 mi)
· Sponsor: Ray Therapeutics, Inc.
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Asthma
Phase 3
Interventional 138 participants sought
GSK Investigational Site — Bakersfield, California (1.7 mi)
· Sponsor: GlaxoSmithKline
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
ADARx Clinical Site — Bakersfield, California (1.7 mi)
· Sponsor: ADARx Pharmaceuticals, Inc.
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Adventist Health - Bakersfield — Bakersfield, California (1.7 mi)
· Sponsor: Agendia
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
Pruritus
Phase 3
Interventional 284 participants sought
Kern Allergy and Medical Research- Site Number : 8400016 — Bakersfield, California (1.7 mi)
· Sponsor: Sanofi
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi)
· Sponsor: NRG Oncology
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Severe Asthma
Phase 3
Interventional 786 participants sought
Research Site 13 — Bakersfield, California (1.7 mi)
· Sponsor: Generate Biomedicines
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Non-Muscle Invasive Bladder Urothelial Carcinoma, Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma
Phase 2
Interventional 160 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
Multiple Myeloma
Phase 1
Interventional 134 participants sought
Comprehensive Blood and Cancer Center — Bakersfield, California (1.7 mi)
· Sponsor: Oncotherapeutics
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
AMD, nAMD
Phase 3
Interventional 714 participants sought
California Retina Consultants - Bakersfield /ID# 256240 — Bakersfield, California (1.7 mi)
· Sponsor: AbbVie